Advertisement

Value of Indirect Pancreatic Function Tests

  • P. G. Lankisch
Conference paper

Abstract

Two principally different procedures are available for investigating exocrine pancreatic function (Table 1):
  1. 1.

    Direct pancreatic function tests, measuring the contents of pancreatic secretion (bicarbonate and enzymes)

     
  2. 2.

    Indirect pancreatic function tests, whereby diminished digestive capability signifies exocrine pancreatic insufficiency.

     

Keywords

Chronic Pancreatitis Enzyme Replacement Therapy Pancreatic Function Exocrine Pancreatic Function Exocrine Pancreatic Insufficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ammann R (1967) Fortschritte in der Pankreasfunktionsdiagnostik. Springer, Berlin Heidelberg New YorkGoogle Scholar
  2. 2.
    Bornschein W (1981) Der PABA-Peptid-Serum Test. Dtsch Med Wochenschr 106:1676–1677Google Scholar
  3. 3.
    Braganza JM, Kay GH, Tetlow VA, Herman KJ (1983) Observations on the BT/PABA/14C-PABA tubeless test of pancreatic function. Clin Chim Acta 130:339–347PubMedCrossRefGoogle Scholar
  4. 4.
    Cavallini G, Piubello W, Brocco G, Micciolo R, Chech G, Angelini G, Benini L, Riela A, dalle Molle L, Vantini I, Scuro LA (1985) Serum PABA and fluorescein in the course of Bz-Ty-PABA and pancreolauryl test as an index of exocrine pancreatic insufficiency. Dig Dis Sci 30:655–663PubMedCrossRefGoogle Scholar
  5. 5.
    Cole SG, Rossi S, Stern A, Hofmann AF (1987) Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function. Gastroenterology 93:1372–1380PubMedGoogle Scholar
  6. 6.
    Delchier JC, Soule JC (1983) BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specifity. Gut 24:318–325PubMedCrossRefGoogle Scholar
  7. 7.
    DiMagno EP, Go VLW, Summerskill WHJ (1973) Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815PubMedCrossRefGoogle Scholar
  8. 8.
    Domschke S, Heptner G, Kolb S, Sailer D, Schneider MU, Domschke W (1986) Decrease in plasma amino acid level after secretin and pancreozymin as an indicator of exocrine pancreatic function. Gastroenterology 90:1031–1038PubMedGoogle Scholar
  9. 9.
    Dürr HK, Otte M, Forell MM, Bode JC (1978) Fecal chymotrypsin: a study on its diagnostic value by comparison with the secretin-cholecystokinin test. Digestion 17:404–409PubMedCrossRefGoogle Scholar
  10. 10.
    Ehrhardt-Schmelzer S, Otto J, Schlaeger R, Lankisch PG (1984) Faecal chymotrypsin for investigation of exocrine pancreatic function: a comparison of two newly developed tests with the titrimetric method. Z Gastroenterol 22:647–651PubMedGoogle Scholar
  11. 11.
    Freise J, Ranft U, Fricke K, Schmidt FW (1984) Chronische Pankreatitis: Sensitivität, Spezifität und prädiktiver Wert des Pankreolauryltests. Z Gastroenterol 22:705–712PubMedGoogle Scholar
  12. 12.
    Gyr K, Felsenfeld O, Imondi AR (1978) Chymotrypsin-like activity of some intestinal bacteria. Am J Dig Dis 23:413–416PubMedCrossRefGoogle Scholar
  13. 13.
    Heptner G, Domschke S, Schneider MU, Kolb S, Domschke W (1987) Aminosäurespiegel im Plasma — dargestellt als a-Amino-Stickstoff — reagieren auf Stimulation des exokrinen Pankreas: Ansätze für einen Pankreasfunktionstest. Klin Wochenschr 65:1054–1061PubMedCrossRefGoogle Scholar
  14. 14.
    Kay G, Hine P, Braganza J (1982) The pancreolauryl test. A method of assessing the combined functional efficacy of pancreatic esterase and bile salts in vivo? Digestion 24:241–245PubMedCrossRefGoogle Scholar
  15. 15.
    Lang C, Gyr K, Tonko I, Conen D, Stalder GA (1984) The value of serum PABA as a pancreatic function test. Gut 25:508–512PubMedCrossRefGoogle Scholar
  16. 16.
    Lankisch PG (1982) Progress report: exocrine pancreatic function tests. Gut 23:777–798PubMedCrossRefGoogle Scholar
  17. 17.
    Lankisch PG, Lembcke B (1984) Indirect pancreatic function tests: chemical and radioisotope methods. Clin Gastroenterol 13:717–737PubMedGoogle Scholar
  18. 18.
    Lankisch PG, Ehrhardt-Schmelzer S, Koop H, Caspary WF (1980) Der NBT-PABA-Test in der Diagnostik der exokrinen Pankreasinsuffizienz. Dtsch Med Wochenschr 105:1418–1423PubMedCrossRefGoogle Scholar
  19. 19.
    Lankisch PG, Schreiber A, Otto J (1983) Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci 28:490–493PubMedCrossRefGoogle Scholar
  20. 20.
    Lankisch PG, Brauneis J, Otto J, Göke B (1986) Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency? Gastroenterology 90:350–354PubMedGoogle Scholar
  21. 21.
    Lankisch PG, Otto J, Brauneis J, Hilgers R, Lembcke B (1988) Detection of pancreatic steatorrhea by oral pancreatic function tests. Dig Dis Sci 33:1233–1236PubMedCrossRefGoogle Scholar
  22. 22.
    Lembcke B (1984) Malassimilationsdiagnostik. In: Caspary WF (ed) Maldigestion, Malabsorption. Klinik, Differentialdiagnose, Therapie. Kali-Chemie Pharma, Hannover, pp 47–86 (Gastroenterologische Reihe, vol 21)Google Scholar
  23. 23.
    Malfertheiner P, Ditschuneit H (1985) Diagnostic procedures in pancreatic disease. Springer, Berlin Heidelberg New YorkGoogle Scholar
  24. 24.
    Malfertheiner P, Peter M, Junge U, Ditschuneit H (1983) Der orale Pankreasfunktionstest mit FDL in der Diagnose der chronischen Pankreatitis. Klin Wochenschr 61:193–198PubMedCrossRefGoogle Scholar
  25. 25.
    Malfertheiner P, Büchler M, Müller A, Ditschuneit H (1987) Fluorescein dilaurate serum test: a rapid tubeless pancreatic function test. Pancreas 2:53–60PubMedCrossRefGoogle Scholar
  26. 26.
    Malfertheiner P, Büchler M, Müller A, Ditschuneit H (1987) Fluoresceindilaurat-Serumtest nach Metoclopramid- und Sekretinstimulation zur Pankreasfunktionsprüfung. Beitrag zur Diagnose der chronischen Pankreatitis. Z Gastroenterol 25:225–232PubMedGoogle Scholar
  27. 27.
    Mitchell CJ, Humphrey CS, Bullen AW, Kelleher J, Losowsky MS (1979) Improved diagnostic accuracy of a modified oral pancreatic function test. Scand J Gastroenterol 14:737–741PubMedCrossRefGoogle Scholar
  28. 28.
    Mitchell CJ, Field HP, Simpson FG, Parkin A, Kelleher J, Losowsky MS (1981) Preliminary evaluation of a single-day tubeless test of pancreatic function. Br Med J 282:1751–1753CrossRefGoogle Scholar
  29. 29.
    Münch R, Bühler H, Ammann R (1983) Chymotrypsinaktivität im Stuhl: Vergleich eines neuen photometrischen Verfahrens mit der titrimetrischen Standardmethode. Schweiz Med Wochenschr 113:1794–1797PubMedGoogle Scholar
  30. 30.
    Schneider MU, Demling L, Jones SA, Barker PJ, Domschke S, Heptner G, Domschke W (1987) NMR spectrometry. A new method for total stool fat quantification in chronic pancreatitis. Dig Dis Sci 32:494–499PubMedCrossRefGoogle Scholar
  31. 31.
    Stock K-P, Schenk J, Schmack B, Domschke W (1981) Funktions-“Screening” des exokrinen Pankreas. FDL-, N-BT-PABA-Test, Stuhl-Chymotrypsinbestimmung im Vergleich mit dem Sekretin-Pankreozymin-Test. Dtsch Med Wochenschr 106:983–987PubMedCrossRefGoogle Scholar
  32. 32.
    Tanner AR, Fisher D, Ward C, Smith CL (1984) An evaluation of the one-day NBT-PABA/14C-PABA in the assessment of pancreatic exocrine insufficiency. Digestion 29:42–46PubMedCrossRefGoogle Scholar
  33. 33.
    Van de Kamer JH, ten Bokkel Huinink H, Weijers HA (1949) Rapid method for the determination of fat in feces. J Biol Chem 177:347–355Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • P. G. Lankisch
    • 1
  1. 1.Department of Internal MedicineMunicipal Hospital of LüneburgLüneburgGermany

Personalised recommendations